Overview Study Evaluating Intepirdine (RVT-101) in Subjects With Dementia With Lewy Bodies: The HEADWAY-DLB Study Status: Completed Trial end date: 2017-12-01 Target enrollment: Participant gender: Summary This study seeks to evaluate the efficacy and safety of intepirdine (RVT-101) in patients with dementia with Lewy bodies. Phase: Phase 2 Details Lead Sponsor: Axovant Sciences Ltd.